HeartSciences increases ATM equity offering limit to $25M in amended distribution agreement

HeartSciences Inc.

Amendment No. 3 to Equity Distribution Agreement raises maximum offering from $15M to $25M of common stock.
Commission rate: 4% on gross proceeds up to $11,036,310; 3% on excess.
Non-affiliate public float ~$14.7M; shelf sales limited to ~$4.9M per 12 months under S-3 I.B.6.
No shares sold under I.B.6 in prior 12 months.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.